Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$32.77K$32.77Kderived+10.0% vs Q4 2016 Net Income-$991.92K-$991.92KderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$28,991N/M Operating Incomederived-$274,939N/M Operating Cash Flowderived-$226,387N/M Margins · derivedGross margin88.5%+642.4 pt vs Q4 2016
Operating margin-838.9%+1087.6 pt vs Q4 2016
Net margin-3026.7%+580.1 pt vs Q4 2016
ended Dec 31, 2017 · filed Apr 17, 2018 · 107 d after period end